NCT04784598

Brief Summary

Introduction: Persistent hindfoot pains are very common and prevalent complaints in the Brazilian population. One of the treatments recommended for these conditions in the literature is the use of insoles. However, to use this resource it is necessary that the individual wear closed shoes and this is an obstacle to treatment in cities with hot climate. Thinking about an alternative treatment, the customized slippers with the corrective elements of the insoles can be an alternative to increase adherence to this type of treatment. Objective: To compare different types of hindfoot elements in insoles adapted in slippers in individuals with persistent hindfoot pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 5, 2021

Completed
1.2 years until next milestone

Study Start

First participant enrolled

May 16, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

January 20, 2023

Status Verified

January 1, 2023

Enrollment Period

5 months

First QC Date

March 1, 2021

Last Update Submit

January 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Numerical pain intensity scale - NPS

    Pain intensity will be evaluated with the 10-point Numerical Pain Rating Scale, where 0 is "pain-free" and 10 is "maximum pain.

    baseline, 6 weeks after, 12 weeks after, 16 weeks folow up

Secondary Outcomes (5)

  • Change in Foot function - FFI

    baseline, 6 weeks after, 12 weeks after, 16 weeks folow up

  • Change in Functional capacity - 6MWT

    baseline and 12 weeks after

  • Change in Pain Catastrophizing Scale (PCS)

    baseline and 12 weeks after

  • Expectation for treatment

    baseline

  • Satisfaction with treatment

    16 weeks after

Study Arms (2)

Experimental group

EXPERIMENTAL

Group 1- The intervention group I will receive a customized strip slipper with a 3mm EVA horseshoe piece (Shore A 32). And 2.5mm EVA cover (Shore A 28).

Other: Insoles adapted in flip-flop sandals

Sham group

SHAM COMPARATOR

Group 2- The control group will receive a slipper with a 2.5mm EVA cover (Shore A 32) identical to the one used by the intervention group, but without corrective par

Other: Insoles adapted in flip-flop sandals

Interventions

participants of both groups individually received a pair of customized flip-flop sandals, with or without foot pieces, covered with smooth synthetic leather

Experimental groupSham group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals of both sexes, aged 18 to 65 years;
  • Persistent heel pain for at least three months based on self-reported criteria: heel pain accompanying the first steps in the morning, after a period of inactivity, and/or during prolonged weight-bearing;
  • Pain intensity between 3 and 8 points, according to the Numerical Rating Scale (NRS) \[22\];
  • Individuals who can wear flip-flop sandals for at least four hours per day for 12 weeks.

You may not qualify if:

  • Clinical diagnosis of neuropathic pain or neurodegenerative disorders, persistent heel pain due to rheumatic conditions, and previous ankle and foot surgeries;
  • Physical therapy treatment in the last three months;
  • Corticosteroid injection into feet in the last six months;
  • inability to answer study-related questionnaires;
  • Individuals scheduled to travel in the next six months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marcelo Cardoso de Souza

Natal, Rio Grande do Norte, 59200-000, Brazil

Location

Related Publications (3)

  • Costa ARA, de Almeida Silva HJ, Mendes AAMT, Scattone Silva R, de Almeida Lins CA, de Souza MC. Effects of insoles adapted in flip-flop sandals in people with plantar fasciopathy: a randomized, double-blind clinical, controlled study. Clin Rehabil. 2020 Mar;34(3):334-344. doi: 10.1177/0269215519893104. Epub 2019 Dec 6.

  • Fagundes MG, Mendes AAMT, Bezerra VF, Freitas WRMS, Scattone Silva R, Pontes-Silva A, Barbosa GM, Cardoso de Souza M. Effects of insoles adapted in flip-flop sandals in patients with persistent plantar heel pain: A sham-controlled randomised trial. Clin Rehabil. 2024 Nov;38(11):1466-1480. doi: 10.1177/02692155241267991. Epub 2024 Aug 2.

  • Fagundes MG, Teixeira Mendes AAM, Barbosa GM, de Souza MC. Effects of insoles adapted in flip-flop sandals for persistent heel pain: a protocol for a sham-controlled randomised trial. BMJ Open. 2022 Nov 7;12(11):e062523. doi: 10.1136/bmjopen-2022-062523.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group 1- (n=40) The participant allocated to the insoles group adapted to flip-flops and classified as having a neutral foot according to the FPI-6 will receive a flip-flop with a horseshoe-type foot element on both feet to maintain symmetry between the limbs. If the participant is classified with the foot pronated or supinated, only the painful foot will be modified since the symmetry of the limbs will not be modified. Participants with pronated foot will receive the medial wedge as a pedal element; already the participants with supinated foot, the lateral wedge. All elements will be 3mm and produced with EVA Shore 32. • Group 2- The control group (n=40) will receive a slipper with a 2.5mm EVA cover (Shore A 32) identical to the one used by the intervention group, but without corrective par.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Professor

Study Record Dates

First Submitted

March 1, 2021

First Posted

March 5, 2021

Study Start

May 16, 2022

Primary Completion

October 1, 2022

Study Completion

January 1, 2023

Last Updated

January 20, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

there is not a plan to make individual participant data (IPD) available to other researchers

Locations